Genetic characterization of Plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology studyResearch in context

Summary: Background: Malaria is a mosquito borne disease caused by parasites of the genus Plasmodium. In 2023, the United States (US) experienced nine cases of autochthonous Plasmodium vivax malaria transmission; seven in Florida, one in Texas, and another in Arkansas. These were the first autochth...

Full description

Saved in:
Bibliographic Details
Main Authors: Joel L.N. Barratt, David Jacobson, Edwin Pierre-Louis, Marko Bajic, Julia Kelley, Dhruviben S. Patel, Ira Goldman, Zhiyong Zhou, Ya Ping Shi, Alison Ridpath, Kimberly Mace, Christina Carlson, Alice Sutcliffe, Qiana Butler, Andrea Morrison, Danielle Stanek, Kelly Tomson, Carina Blackmore, Andrew Cannons, Susan Rollo, Chun Wang, Rashmi Tuladhar, Brooke Clemons, Susan Madison-Antenucci, Kimberly Mergen, Jennifer White, Mike Antwi, Laura Rothfeldt, Katelyn Lazenby, Stephen Hedges, Jennifer N. Shray, Ashleah Courtney, Bobby Boyanton, Yvonne Qvarnstrom, Molly Freeman, Brian H. Raphael
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:The Lancet Regional Health. Americas
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667193X25001693
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850114427208073216
author Joel L.N. Barratt
David Jacobson
Edwin Pierre-Louis
Marko Bajic
Julia Kelley
Dhruviben S. Patel
Ira Goldman
Zhiyong Zhou
Ya Ping Shi
Alison Ridpath
Kimberly Mace
Christina Carlson
Alice Sutcliffe
Qiana Butler
Andrea Morrison
Danielle Stanek
Kelly Tomson
Carina Blackmore
Andrew Cannons
Susan Rollo
Chun Wang
Rashmi Tuladhar
Brooke Clemons
Susan Madison-Antenucci
Kimberly Mergen
Jennifer White
Mike Antwi
Laura Rothfeldt
Katelyn Lazenby
Stephen Hedges
Jennifer N. Shray
Ashleah Courtney
Bobby Boyanton
Yvonne Qvarnstrom
Molly Freeman
Brian H. Raphael
author_facet Joel L.N. Barratt
David Jacobson
Edwin Pierre-Louis
Marko Bajic
Julia Kelley
Dhruviben S. Patel
Ira Goldman
Zhiyong Zhou
Ya Ping Shi
Alison Ridpath
Kimberly Mace
Christina Carlson
Alice Sutcliffe
Qiana Butler
Andrea Morrison
Danielle Stanek
Kelly Tomson
Carina Blackmore
Andrew Cannons
Susan Rollo
Chun Wang
Rashmi Tuladhar
Brooke Clemons
Susan Madison-Antenucci
Kimberly Mergen
Jennifer White
Mike Antwi
Laura Rothfeldt
Katelyn Lazenby
Stephen Hedges
Jennifer N. Shray
Ashleah Courtney
Bobby Boyanton
Yvonne Qvarnstrom
Molly Freeman
Brian H. Raphael
author_sort Joel L.N. Barratt
collection DOAJ
description Summary: Background: Malaria is a mosquito borne disease caused by parasites of the genus Plasmodium. In 2023, the United States (US) experienced nine cases of autochthonous Plasmodium vivax malaria transmission; seven in Florida, one in Texas, and another in Arkansas. These were the first autochthonous cases since 2003 when a cluster was identified in Florida. The aim of this study was to genetically characterize the implicated P. vivax isolates in order to complement epidemiologic investigations of these cases. Methods: A custom Illumina AmpliSeq sequencing panel capturing 495 amplicons was designed. This panel was used to ascertain whether these 2023 cases were related, and assess if they were associated with a single or separate introduction events. Sequence data were hierarchically clustered and a Naïve Bayes classification approach was used to assign genotypes to a probable geographic origin based on 113 ‘geo-informative’ SNPs captured by the panel. Genotypes associated with the 2023 Arkansas, Texas, and Florida cases were clustered alongside those sequenced from archived blood samples from the 2003 Florida case-patients, a set of reference strains, and other travel-associated specimens. Microsatellite analysis was performed on a subset of samples from these autochthonous cases to complement the AmpliSeq analysis. Findings: The 2023 autochthonous Florida cases were genetically linked as were the 2003 Florida cases. The 2023 and 2003 Florida clusters were genetically distinct, and the two Florida clusters were distinct from the 2023 Texas and Arkansas cases, which were also distinct from each other. These genotypes classified to the Central or South American region using the Naïve Bayes classifier, including those from the 2003 cluster. Interpretation: These data support that at least three distinct P. vivax introduction events in the US in 2023, involving parasites possessing genetic signatures consistent with Central or South America. Funding: This work was supported by the National Center for Emerging and Zoonotic Infectious Diseases at the US Centers for Disease Control and Prevention.
format Article
id doaj-art-5b444a5e9f084d27b7d6b98e955ff0e8
institution OA Journals
issn 2667-193X
language English
publishDate 2025-08-01
publisher Elsevier
record_format Article
series The Lancet Regional Health. Americas
spelling doaj-art-5b444a5e9f084d27b7d6b98e955ff0e82025-08-20T02:36:53ZengElsevierThe Lancet Regional Health. Americas2667-193X2025-08-014810115910.1016/j.lana.2025.101159Genetic characterization of Plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology studyResearch in contextJoel L.N. Barratt0David Jacobson1Edwin Pierre-Louis2Marko Bajic3Julia Kelley4Dhruviben S. Patel5Ira Goldman6Zhiyong Zhou7Ya Ping Shi8Alison Ridpath9Kimberly Mace10Christina Carlson11Alice Sutcliffe12Qiana Butler13Andrea Morrison14Danielle Stanek15Kelly Tomson16Carina Blackmore17Andrew Cannons18Susan Rollo19Chun Wang20Rashmi Tuladhar21Brooke Clemons22Susan Madison-Antenucci23Kimberly Mergen24Jennifer White25Mike Antwi26Laura Rothfeldt27Katelyn Lazenby28Stephen Hedges29Jennifer N. Shray30Ashleah Courtney31Bobby Boyanton32Yvonne Qvarnstrom33Molly Freeman34Brian H. Raphael35Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USA; Corresponding author.Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USA; Oak Ridge Associated Universities – ORAU, P.O. Box 117, MS-36, Oak Ridge, TN, 37831-0117, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USA; US President's Malaria Initiative, Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USAFlorida Department of Health, 4052 Bald Cypress Way, Tallahassee, FL, 32399, USAFlorida Department of Health, 4052 Bald Cypress Way, Tallahassee, FL, 32399, USAFlorida Department of Health, 4052 Bald Cypress Way, Tallahassee, FL, 32399, USAFlorida Department of Health, 4052 Bald Cypress Way, Tallahassee, FL, 32399, USABureau of Public Health Laboratories-Tampa, 3602 Spectrum Blvd, Tampa, FL, 33612, USATexas Department of State Health Services, 1100 West 49th Street, Austin, TX, 78756-3199, USATexas Department of State Health Services, 1100 West 49th Street, Austin, TX, 78756-3199, USATexas Department of State Health Services, 1100 West 49th Street, Austin, TX, 78756-3199, USANew York State Department of Health Wadsworth Center, 120 New Scotland Ave, Albany, NY, 12208, USANew York State Department of Health Wadsworth Center, 120 New Scotland Ave, Albany, NY, 12208, USANew York State Department of Health Wadsworth Center, 120 New Scotland Ave, Albany, NY, 12208, USANew York State Department of Health, Empire State Plaza, Albany, NY, 12237, USANYC Department of Health and Mental Hygiene, 42-09 28th St., Long Island City, NY, 11101, USAArkansas Department of Health, Zoonotic Disease Section, 4815 W. Markham, Little Rock, AR, 72205, USAArkansas Department of Health, Zoonotic Disease Section, 4815 W. Markham, Little Rock, AR, 72205, USAArkansas Department of Health, Zoonotic Disease Section, 4815 W. Markham, Little Rock, AR, 72205, USAArkansas Department of Health, Glen F. Baker Public Health Lab., 201 S. Monroe Street, Little Rock, AR, 72205, USAArkansas Children's Hospital, 1 Children's Way, Little Rock, AR, 72202, USA; University of Arkansas for Medical Sciences, Little Rock, AR, USAArkansas Children's Hospital, 1 Children's Way, Little Rock, AR, 72202, USA; University of Arkansas for Medical Sciences, Little Rock, AR, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USACenters for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Parasitic Diseases and Malaria, 1600 Clifton Road, Atlanta, GA, 30329, USA; Corresponding author.Summary: Background: Malaria is a mosquito borne disease caused by parasites of the genus Plasmodium. In 2023, the United States (US) experienced nine cases of autochthonous Plasmodium vivax malaria transmission; seven in Florida, one in Texas, and another in Arkansas. These were the first autochthonous cases since 2003 when a cluster was identified in Florida. The aim of this study was to genetically characterize the implicated P. vivax isolates in order to complement epidemiologic investigations of these cases. Methods: A custom Illumina AmpliSeq sequencing panel capturing 495 amplicons was designed. This panel was used to ascertain whether these 2023 cases were related, and assess if they were associated with a single or separate introduction events. Sequence data were hierarchically clustered and a Naïve Bayes classification approach was used to assign genotypes to a probable geographic origin based on 113 ‘geo-informative’ SNPs captured by the panel. Genotypes associated with the 2023 Arkansas, Texas, and Florida cases were clustered alongside those sequenced from archived blood samples from the 2003 Florida case-patients, a set of reference strains, and other travel-associated specimens. Microsatellite analysis was performed on a subset of samples from these autochthonous cases to complement the AmpliSeq analysis. Findings: The 2023 autochthonous Florida cases were genetically linked as were the 2003 Florida cases. The 2023 and 2003 Florida clusters were genetically distinct, and the two Florida clusters were distinct from the 2023 Texas and Arkansas cases, which were also distinct from each other. These genotypes classified to the Central or South American region using the Naïve Bayes classifier, including those from the 2003 cluster. Interpretation: These data support that at least three distinct P. vivax introduction events in the US in 2023, involving parasites possessing genetic signatures consistent with Central or South America. Funding: This work was supported by the National Center for Emerging and Zoonotic Infectious Diseases at the US Centers for Disease Control and Prevention.http://www.sciencedirect.com/science/article/pii/S2667193X25001693MalariaAutochthonousPlasmodium vivaxUSATransmissionSequencing
spellingShingle Joel L.N. Barratt
David Jacobson
Edwin Pierre-Louis
Marko Bajic
Julia Kelley
Dhruviben S. Patel
Ira Goldman
Zhiyong Zhou
Ya Ping Shi
Alison Ridpath
Kimberly Mace
Christina Carlson
Alice Sutcliffe
Qiana Butler
Andrea Morrison
Danielle Stanek
Kelly Tomson
Carina Blackmore
Andrew Cannons
Susan Rollo
Chun Wang
Rashmi Tuladhar
Brooke Clemons
Susan Madison-Antenucci
Kimberly Mergen
Jennifer White
Mike Antwi
Laura Rothfeldt
Katelyn Lazenby
Stephen Hedges
Jennifer N. Shray
Ashleah Courtney
Bobby Boyanton
Yvonne Qvarnstrom
Molly Freeman
Brian H. Raphael
Genetic characterization of Plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology studyResearch in context
The Lancet Regional Health. Americas
Malaria
Autochthonous
Plasmodium vivax
USA
Transmission
Sequencing
title Genetic characterization of Plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology studyResearch in context
title_full Genetic characterization of Plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology studyResearch in context
title_fullStr Genetic characterization of Plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology studyResearch in context
title_full_unstemmed Genetic characterization of Plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology studyResearch in context
title_short Genetic characterization of Plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology studyResearch in context
title_sort genetic characterization of plasmodium vivax linked to autochthonous malaria transmission in the us 2023 using illumina ampliseq technology a genetic epidemiology studyresearch in context
topic Malaria
Autochthonous
Plasmodium vivax
USA
Transmission
Sequencing
url http://www.sciencedirect.com/science/article/pii/S2667193X25001693
work_keys_str_mv AT joellnbarratt geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT davidjacobson geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT edwinpierrelouis geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT markobajic geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT juliakelley geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT dhruvibenspatel geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT iragoldman geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT zhiyongzhou geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT yapingshi geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT alisonridpath geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT kimberlymace geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT christinacarlson geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT alicesutcliffe geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT qianabutler geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT andreamorrison geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT daniellestanek geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT kellytomson geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT carinablackmore geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT andrewcannons geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT susanrollo geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT chunwang geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT rashmituladhar geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT brookeclemons geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT susanmadisonantenucci geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT kimberlymergen geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT jenniferwhite geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT mikeantwi geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT laurarothfeldt geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT katelynlazenby geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT stephenhedges geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT jennifernshray geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT ashleahcourtney geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT bobbyboyanton geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT yvonneqvarnstrom geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT mollyfreeman geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext
AT brianhraphael geneticcharacterizationofplasmodiumvivaxlinkedtoautochthonousmalariatransmissionintheus2023usingilluminaampliseqtechnologyageneticepidemiologystudyresearchincontext